Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Indian J Dermatol Venereol Leprol ; 89(4): 572-577, 2023.
Article in English | MEDLINE | ID: mdl-35962511

ABSTRACT

Background Despite acne being a common dermatological problem, there is a paucity of literature addressing the knowledge, attitude and practice about it. Aims/Objectives To find out what patients know about acne, its cause and treatment, as well as myths, misconceptions and attitude towards it. Methods A cross-sectional, descriptive questionnaire-based study on acne patients at Maharana Bhupal Hospital, RNT Medical College, Udaipur, Rajasthan, India. Results Most (84.8%) patients belonged to the age group of 16-25 years. The majority (63.9%) presented 12 months after the onset of acne. More than half had average knowledge, a positive attitude and good practices, related significantly to gender and education. Limitations A standardized questionnaire suitable for all dialects and regional languages would have yielded more uniform results. Conclusion Study revealed that acne patients still need to acquire accurate, adequate and easily accessible information to seek timely and appropriate treatment, and alleviate their psychological suffering.


Subject(s)
Acne Vulgaris , Humans , Adolescent , Young Adult , Adult , Cross-Sectional Studies , India/epidemiology , Acne Vulgaris/diagnosis , Acne Vulgaris/epidemiology , Acne Vulgaris/therapy , Surveys and Questionnaires , Educational Status
6.
Indian J Dermatol Venereol Leprol ; 82(6): 603-625, 2016.
Article in English | MEDLINE | ID: mdl-27716721

ABSTRACT

BACKGROUND: Stevens-Johnson syndrome and toxic epidermal necrolysis are severe, life-threatening mucocutaneous adverse drug reactions with a high morbidity and mortality that require immediate medical care. The various immunomodulatory treatments include systemic corticosteroids, cyclosporine, intravenous immunoglobulin, cyclophosphamide, plasmapheresis and tumor necrosis factor-α inhibitors. AIM: The ideal therapy of Stevens-Johnson syndrome/toxic epidermal necrolysis still remains a matter of debate as there are only a limited number of studies of good quality comparing the usefulness of different specific treatments. The aim of this article is to comprehensively review the published medical literature and frame management guidelines suitable in the Indian perspective. METHODS: The Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) assigned the task of preparing these guidelines to its special interest group on cutaneous adverse drug reactions. The group performed a comprehensive English language literature search for management options in Stevens-Johnson syndrome/toxic epidermal necrolysis across multiple databases (PubMed, EMBASE, MEDLINE and Cochrane) for keywords (alone and in combination) and MeSH items such as "guidelines," "Stevens-Johnson syndrome," "toxic epidermal necrolysis," "corticosteroids," "intravenous immunoglobulin," "cyclosporine" and "management." The available evidence was evaluated using the strength of recommendation taxonomy and graded using a three-point scale. A draft of clinical recommendations was developed on the best available evidence which was also scrutinized and critically evaluated by the IADVL Academy of Dermatology. Based on the inputs received, this final consensus statement was prepared. RESULTS: A total of 104 articles (meta-analyses, prospective and retrospective studies, reviews [including chapters in books], previous guidelines [including Indian guidelines of 2006] and case series) were critically evaluated and the evidence thus gathered was used in the preparation of these guidelines. RECOMMENDATIONS: This expert group recommends prompt withdrawal of the culprit drug, meticulous supportive care, and judicious and early (preferably within 72 h) initiation of moderate to high doses of oral or parenteral corticosteroids (prednisolone 1-2 mg/kg/day or equivalent), tapered rapidly within 7-10 days. Cyclosporine (3-5 mg/kg/day) for 10-14 days may also be used either alone, or in combination with corticosteroids. Owing to the systemic nature of the disease, a multidisciplinary approach in the management of these patients is helpful.


Subject(s)
Disease Management , Practice Guidelines as Topic/standards , Stevens-Johnson Syndrome/epidemiology , Stevens-Johnson Syndrome/therapy , Adrenal Cortex Hormones/therapeutic use , Cyclosporine/therapeutic use , Humans , Immunoglobulins, Intravenous/therapeutic use , India/epidemiology , Prednisolone/therapeutic use , Prospective Studies , Retrospective Studies , Stevens-Johnson Syndrome/diagnosis
12.
Article in English | MEDLINE | ID: mdl-17656922

ABSTRACT

Bleomycin frequently causes cutaneous toxicity in the form of pigmentary disturbances. We report 2 patients with testicular tumours who developed distinctive "flagellate" pigmentation on trunk and extremities during bleomycin therapy.

SELECTION OF CITATIONS
SEARCH DETAIL